Autek China Inc. Stock price

Equities

300595

CNE100002MR0

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
17.91 CNY +0.17% Intraday chart for Autek China Inc. -9.18% -20.68%
Sales 2023 * 1.71B 237M Sales 2024 * 2.17B 300M Capitalization 16.07B 2.23B
Net income 2023 * 698M 96.68M Net income 2024 * 871M 121M EV / Sales 2023 * 8.2 x
Net cash position 2023 * 2.03B 281M Net cash position 2024 * 2.6B 361M EV / Sales 2024 * 6.21 x
P/E ratio 2023 *
22.7 x
P/E ratio 2024 *
18.7 x
Employees 1,926
Yield 2023 *
0.77%
Yield 2024 *
1.05%
Free-Float 47.99%
More Fundamentals * Assessed data
Dynamic Chart
Nomura Adjusts Ovctek China’s Price Target to 22.16 Yuan From 25.69 Yuan, Keeps at Neutral MT
Autek China Inc. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts Ovctek China's Price Target to 30.19 Yuan From 33.83 Yuan, Keeps at Neutral MT
Autek China Logs Double-Digit Earnings Growth in H1 MT
Autek China Inc. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Autek China Elects Founder as Chairman, General Manager MT
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Shenzhen Mingmou Ruishi Eye Clinic from Zhao Xiaoting, and Li Xianting for CNY 20.7 million. CI
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Kunming Shikang Eye Clinic Co., Ltd. from Yunnan Shilikang Enterprise Management Partnership Enterprise (Limited Partnership), Zhang Mingjing, and Ouyang Zhonghua for CNY 58.2 million. CI
Autek China Inc. agreed to acquire an additional 30% stake in Xuancheng Autek Baixiu Medical Devices Co., Ltd. from Huang Guanglu and Liu Jihua for CNY 21.93 million CI
Autek China Inc. agreed to acquire an additional 38.99% stake in Xuancheng Mengdaiwei Medical Devices Co., Ltd. from Huangyan Yulu and Hu Chenying for CNY 21.15 million CI
Autek China Inc. entered into an agreement to acquire additional 39% stake in Quanzhou Autek Optical Technology Co., Ltd. from Zhuang Chaoyang, and Zheng Jing for approximately CNY 30 million. CI
Autek Investment Co., Ltd. entered into an agreement to acquire 39% stake in Suzhou Kangshi Health Eye Information Consulting Co., Ltd. from Yuan Lili and Sun Weiling for CNY 107 million. CI
Autek China Inc. agreed to acquire a 39% stake in Xiantao Jiashi Eye Clinic Co., Ltd. from Wang Tiehan for CNY 17.41 million CI
Autek China Inc. signed the share transfer agreement to acquire an additional 39% stake in Bengbu Autek Optical Equipment Technology Co., Ltd. from Shi Jing for CNY 45 million. CI
Autek China Inc. signed the share transfer agreement to acquire a 39% stake in Xuancheng Dental Hospital Co., Ltd. from Huang Chaohui, He Xiaoqing for CNY 16.3 million. CI
More news
1 day+0.17%
1 week-9.18%
Current month-13.02%
1 month-11.20%
3 months-20.01%
6 months-30.26%
Current year-20.68%
More quotes
1 week
17.75
Extreme 17.75
19.09
1 month
17.75
Extreme 17.75
21.21
Current year
15.20
Extreme 15.2
22.65
1 year
15.20
Extreme 15.2
38.49
3 years
15.20
Extreme 15.2
109.70
5 years
13.54
Extreme 13.5397
109.70
10 years
2.33
Extreme 2.3328
109.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 64 00-10-25
Director of Finance/CFO 42 20-05-06
Chief Tech/Sci/R&D Officer 41 18-05-10
Members of the board TitleAgeSince
Director/Board Member 58 20-05-06
Director/Board Member 62 23-04-25
Chief Executive Officer 64 00-10-25
More insiders
Date Price Change Volume
24-03-28 17.91 +0.17% 9,844,365
24-03-27 17.88 -3.04% 6,678,028
24-03-26 18.44 -0.32% 6,196,419
24-03-25 18.5 -2.68% 7,577,533
24-03-22 19.01 -3.60% 9,590,088

End-of-day quote Shenzhen S.E., March 27, 2024

More quotes
OVCTEK CHINA INC. is a China-based company principally engaged in the research and development, production and sales of eye-sight products and the provision of eye-sight services. The Company's main business is non-surgical vision correction. The Company's main products include orthokeratology, general contact lens and care products. Its core product is Dream David orthokeratology. In addition, The Company is also engaged in general glass frame sales business. The Company mainly operates its business in the domestic market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
17.91 CNY
Average target price
30.74 CNY
Spread / Average Target
+71.63%
Consensus
  1. Stock
  2. Equities
  3. Stock Autek China Inc. - Shenzhen S.E.